MOH INVESTOR NOTICE: Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims related to undisclosed adverse financial information during the specified class period from February 5, 2025, to July 23, 2025 [1][3]. Summary by Sections Class Action Details - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and investors who acquired Molina securities during the class period have until December 2, 2025, to seek lead plaintiff status [1][2]. - The law firm Robbins Geller Rudman & Dowd LLP is representing the plaintiffs in this case [7]. Allegations Against Molina Healthcare - The lawsuit alleges that Molina Healthcare failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [3]. - It is claimed that Molina's near-term growth relied on reduced utilization of various healthcare services, which was not communicated to investors [3]. Financial Performance and Impact - On July 7, 2025, Molina reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - Following this announcement, Molina's stock price declined significantly, reflecting investor concerns over the company's financial guidance being cut by 10.2% at the midpoint for fiscal year 2025 [4]. - On July 23, 2025, Molina further reduced its full-year earnings guidance, reporting a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and attributing this to a challenging medical cost trend environment [5]. The stock price fell nearly 17% after this news [5].